What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Juan A. Pineda mainly focuses on Internal medicine, Hepatitis C virus, Immunology, Gastroenterology and Virology.
His Internal medicine research is multidisciplinary, incorporating elements of Coinfection and Surgery.
His Hepatitis C virus research is multidisciplinary, incorporating perspectives in Viral disease and Hepatitis C.
His work carried out in the field of Immunology brings together such families of science as Odds ratio, Acquired immunodeficiency syndrome and Incidence.
Juan A. Pineda usually deals with Gastroenterology and limits it to topics linked to Liver biopsy and Fibrosis.
His work deals with themes such as Asymptomatic and Polymerase chain reaction, which intersect with Virology.
His most cited work include:
- HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis (239 citations)
- Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. (208 citations)
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy (176 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Hepatitis C virus, Gastroenterology, Virology and Immunology.
His research in Internal medicine intersects with topics in Coinfection and Ribavirin.
His Hepatitis C virus study combines topics in areas such as Liver disease, Viral load and Cohort.
The study incorporates disciplines such as Fibrosis, Pathology, Liver biopsy and Confidence interval in addition to Gastroenterology.
The Virology study combines topics in areas such as Antibody, Serology, Allele and Genotype.
His Immunology research includes themes of Odds ratio and Acquired immunodeficiency syndrome.
He most often published in these fields:
- Internal medicine (55.85%)
- Hepatitis C virus (38.03%)
- Gastroenterology (35.64%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (55.85%)
- Hepatitis C virus (38.03%)
- Gastroenterology (35.64%)
In recent papers he was focusing on the following fields of study:
Juan A. Pineda focuses on Internal medicine, Hepatitis C virus, Gastroenterology, Hepatitis C and Cirrhosis.
Internal medicine and Coinfection are frequently intertwined in his study.
Hepatitis C virus is a subfield of Virology that Juan A. Pineda investigates.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Prospective cohort study and Propensity score matching.
Juan A. Pineda has researched Hepatitis C in several fields, including Ribavirin, Sofosbuvir and Health policy.
His studies in Cirrhosis integrate themes in fields like Clinical endpoint and Genotype.
Between 2017 and 2021, his most popular works were:
- Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. (56 citations)
- Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. (37 citations)
- Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project (29 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Juan A. Pineda mostly deals with Internal medicine, Hepatitis C virus, Gastroenterology, Hepatitis C and Cirrhosis.
His Internal medicine research incorporates themes from Tenofovir alafenamide, Ribavirin and Cobicistat.
His research integrates issues of Drug, Epidemiology and Genotype in his study of Hepatitis C virus.
Juan A. Pineda studies Gastroenterology, focusing on Bilirubin in particular.
As part of the same scientific family, Juan A. Pineda usually focuses on Hepatitis C, concentrating on Sofosbuvir and intersecting with Viral hepatitis.
His Cirrhosis research is multidisciplinary, incorporating elements of Retrospective cohort study, Confidence interval, Hepatocellular carcinoma, Albumin and Coinfection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
